Cargando…
Circulating tumor cell detection and single‐cell analysis using an integrated workflow based on ChimeraX(®)‐i120 Platform: A prospective study
Circulating tumor cell (CTC) analysis holds great potential to be a noninvasive solution for clinical cancer management. A complete workflow that combined CTC detection and single‐cell molecular analysis is required. We developed the ChimeraX(®)‐i120 platform to facilitate negative enrichment, immun...
Autores principales: | Wang, Peng‐Xiang, Sun, Yun‐Fan, Jin, Wei‐Xiang, Cheng, Jian‐Wen, Peng, Hai‐Xiang, Xu, Yang, Zhou, Kai‐Qian, Chen, Li‐Meng, Huang, Kai, Wu, Sui‐Yi, Hu, Bo, Zhang, Ze‐Fan, Guo, Wei, Cao, Ya, Zhou, Jian, Fan, Jia, Yang, Xin‐Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410565/ https://www.ncbi.nlm.nih.gov/pubmed/33301640 http://dx.doi.org/10.1002/1878-0261.12876 |
Ejemplares similares
-
UCSF ChimeraX: Tools for structure building and analysis
por: Meng, Elaine C., et al.
Publicado: (2023) -
PICKLUSTER: a protein-interface clustering and analysis plug-in for UCSF ChimeraX
por: Genz, Luca R, et al.
Publicado: (2023) -
ArtiaX: An electron tomography toolbox for the interactive handling of sub‐tomograms in UCSF ChimeraX
por: Ermel, Utz H., et al.
Publicado: (2022) -
Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma
por: Zhou, Kai-Qian, et al.
Publicado: (2020) -
Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study
por: Wang, Peng‐Xiang, et al.
Publicado: (2020)